ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2128

Effectiveness of 18f-Fluoro-Dexoxyglucose Positron Emission Tomography for the Diagnosis of Polymyalgia-like Illness

Hideyuki Horikoshi1, Takashi Nakanishi1, Reiko Takahashi1, Fumihiko Kimura2 and Kenji Itoh1, 1Division of Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan, 2National Defense Medical College, Tokorozawa, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Infection, Paraneoplastic, polymyalgia rheumatica and positron emission tomography (PET)

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Various Imaging Techniques

Session Type: Abstract Submissions (ACR)

Background/Purpose: Polymyalgia rheumatica (PMR) is an inflammatory condition that affects the elderly.  It is characterized by pain and stiffness in the shoulder and pelvic girdles.  Various inflammatory conditions such as infection, vasculitis, and neoplasms can mimic PMR.  Owing to the low specificity of the diagnostic criteria of PMR, it is often difficult to distinguish PMR from the so-called “polymyalgia-like illness.”  In previous reports of PMR imaging studies, rheumatic diseases such as rheumatoid arthritis were used as controls.  Therefore, the differentiation of PMR from polymyalgia-like illness including paraneoplastic syndrome has not been discussed yet. Herein we performed 18f-Fluoro-Dexoxyglucose Positron Emission Tomography (FDG-PET/CT) in polymyalgia-like illness, and report on the findings.

Methods: Twenty-five cases of polymyalgia-like illness (PMR, 17 cases; paraneoplastic syndrome, 3; infection, 2; vasculitis, 1; others, 2) were analyzed using FDG-PET/CT.

Results: All patients met the diagnostic criteria of Bird et al. and the 2012 ACR/EULAR criteria.  The average scores of PMR and non-PMR cases using these criteria were 4.35 and 4.13, respectively, and no differences were observed between these two groups in clinical presentations.  FDG-PET/CT revealed that all PMR cases showed a high FDG uptake in PMR-specific accumulation sites, including the shoulder joints, sternoclavicular joints, hip joints, spinous processes, ischial tuberosities, and greater trochanters.  However, non-PMR cases showed various patterns of accumulation.  Furthermore, no non-PMR case showed a high FDG uptake in the PMR-specific accumulation sites.

Conclusion: These results indicate the usefulness of FDG-PET/CT for the differential diagnosis of polymyalgia-like illness including paraneoplastic syndrome.  Together with the current diagnostic criteria, accumulation of FDG in PMR-specific sites is useful to more accurately diagnose PMR.  Various patterns of FDG uptake on FDG-PET/CT in patients with polymyalgia-like illness reveal the diversity of pathogenesis in similar clinical presentations.

�à–¾: Macintosh HD:Users:hideyukihorikoshi:Documents:Desktop Groups:Rheumatology study:PMR PET:PMR ACR 2014:ACR PMR figure:figure 1.gif

�à–¾: Macintosh HD:Users:hideyukihorikoshi:Documents:Desktop Groups:Rheumatology study:PMR PET:PMR ACR 2014:ACR PMR figure:figure 2.gif


Disclosure:

H. Horikoshi,
None;

T. Nakanishi,
None;

R. Takahashi,
None;

F. Kimura,
None;

K. Itoh,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-18f-fluoro-dexoxyglucose-positron-emission-tomography-for-the-diagnosis-of-polymyalgia-like-illness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology